close
Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com.
A Japanese health ministry panel on Monday recommended approval of the Alzheimer’s disease treatment Leqembi, following standard approval for the drug granted by U.S. regulators last month.
REVANCE’S BOTOX RIVAL GETS FDA APPROVAL FOR PAINFUL NECK MUSCLE CONDITION
The expert panel’s decision sets the stage for official approval of the drug, co-developed by Japan’s Eisai and U.S.-based Biogen.
Dr. Seth Gale points out evidence of Alzheimer’s disease on PET scans at the Center for Alzheimer Research and Treatment (CART) at Brigham and Women’s Hospital in Boston, Massachusetts, on March 30, 2023. (REUTERS/Brian Snyder/File Photo)
An Eisai executive said this month the company expects to begin marketing Leqembi in Japan within about 60 days of receiving insurance reimbursement approval from the country’s national health system.
CLICK HERE TO GET THE FOX NEWS APP
New research suggests Mars could have enough water under its surface to form a global…
The Perseid meteor shower peaks late Sunday night, and given that it will be paired…
An Italian-led team of scientists say they have confirmed evidence of a sizable cave on…
Rep. Anna Paulina Luna, R-Fla., is now threatening to force a vote on a measure…
Michigan Gov. Gretchen Whitmer took to social media to call out critics who say President…
Former Iowa Senator Tom Harkin, who served with President Biden in Congress for over 20…